Aurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780

Molecular Biology of the Cell

Volumn 20, Issue 8, 2009, Pages 2218-2228

  Nair, Jayasree S ^a   Ho, Alan L ^a   Tse, Archie N ^a   Coward, Jesse ^a   Cheema, Haider ^a   Ambrosini, Grazia ^a   Keen, Nicholas ^b   Schwartz, Gary K ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[3 [4 [5 [2 (3 FLUOROANILINO) 2 OXOETHYL] 1H PYRAZOL 3 YLAMINO] 7 QUINAZOLINYLOXY]PROPYL](ETHYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE; AURORA B KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL FATE; CONTROLLED STUDY; CYTOKINESIS; ENDOREDUPLICATION; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS; PHENOTYPE; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TUMOR CELL;

AMINO ACID SEQUENCE; HCT116 CELLS; HISTONES; HUMANS; MITOSIS; MOLECULAR SEQUENCE DATA; PHOSPHORIC ACID ESTERS; PHOSPHORYLATION; PHOSPHOSERINE; POLYPLOIDY; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; QUINAZOLINES; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65249093721     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-08-0885     Document Type: Article

References (45)

1. Andreassen, P. R., Lacroix, F. B., Lohez, O. D., and Margolis, R. L. (2001a). Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res. 61, 7660-7668.
2. Andreassen, P. R., Lohez, O. D., Lacroix, F. B., and Margolis, R. L. (2001b). Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol. Biol. Cell 12, 1315-1328.
3. Andrews, P. D., Knatko, E., Moore, W. J., and Swedlow, J. R. (2003). Mitotic mechanics: the auroras come into view. Curr. Opin. Cell Biol. 15, 672-683.
4. Avni, D., Yang, H., Martelli, F., Hofmann, F., ElShamy, W. M., Ganesan, S., Scully, R., and Livingston, D. M. (2003). Active localization of the retinoblas-toma protein in chromatin and its response to S phase DNA damage. Mol. Cell 12, 735-746.
5. Borel, F., Lohez, O. D., Lacroix, F. B., and Margolis, R. L. (2002). Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc. Natl. Acad. Sci. USA 99, 9819-9824.
6. Carmena, M., and Earnshaw, W. C. (2003). The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol. 4, 842-854.
7. Carvajal, R. D., Tse, A., and Schwartz, G. K. (2006). Aurora kinases: new targets for cancer therapy. Clin. Cancer Res. 12, 6869-6875.
8. Chan, F., et al. (2007). Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity. Mol. Cancer Ther. 6, 3147-3157.
9. Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., and Sassone-Corsi, P. (2002). Mitotic phosphorylation of histone H 3, spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22, 874-885.
10. Leonardo, A., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., and Wahl, G. M. (1997). DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57, 1013-1019.
11. Ditchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., and Taylor, S. S. (2003). Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. 161, 267-280.
12. Ducat, D., and Zheng, Y. (2004). Aurora kinases in spindle assembly and chromosome segregation. Exp. Cell Res. 301, 60-67.
13. Ezhevsky, S. A.,Ho, A.,Becker-Hapak,M.,Davis,P. K.,and Dowdy,S. F. (2001). Differential regulation of retinoblastoma tumor suppressor protein by G(1) cy-clin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21, 4773-4784.
14. Fraizer, G. C., Diaz, M. F., Lee, I. L., Grossman, H. B., and Sen, S. (2004). Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int. J. Oncol. 25, 1631-1639.
15. Giacinti, C., and Giordano, A. (2006). RB and cell cycle progression. Oncogene 25, 5220-5227.
16. Giet, R., and Glover, D. M. (2001). Drosophila aurora B kinase is required for histone H3 phosphorylation and condensin recruitment during chromosome condensation and to organize the central spindle during cytokinesis. J. Cell Biol. 152, 669-682.
17. Giet, R., Petretti, C., and Prigent, C. (2005). Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 15, 241-250.
18. Gizatullin, F., Yao, Y., Kung, V., Harding, M. W., Loda, M., and Shapiro, G. I. (2006). The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmi-totic checkpoint function. Cancer Res. 66, 7668-7677.
19. Hannak, E., Kirkham, M., Hyman, A. A., and Oegema, K. (2001). Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans. J. Cell Biol. 155, 1109-1116.
20. Harrington, E. A., et al. (2004). VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 10, 262-267.
21. Hauf, S., Cole, R. W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C. L., and Peters, J. M. (2003). The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161, 281-294.
22. Hsu, J. Y., et al. (2000). Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102, 279-291.
23. Katayama, H., Ota, T., Jisaki, F., Ueda, Y., Tanaka, T., Odashima, S., Suzuki, F., Terada, Y., and Tatsuka, M. (1999). Mitotic kinase expression and colorectal cancer progression. J. Natl. Cancer Inst. 91, 1160-1162.
24. Keen, N., and Taylor, S. (2004). Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer 4, 927-936.
25. Kufer, T. A., Sillje, H. H., Korner, R., Gruss, O. J., Meraldi, P., and Nigg, E. A. (2002). Human TPX2 is required for targeting Aurora-A kinase to the spindle. J. Cell Biol. 158, 617-623.
26. Lam, E. W., and La Thangue, N. B. (1994). DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6, 859-866.
27. Lampson, M. A., and Kapoor, T. M. (2005). The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat. Cell Biol. 7, 93-98.
28. Lanni, J. S., and Jacks, T. (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055-1064.
29. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P., and Jorgensen, T. J. (2005). Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteom. 4, 873-886.
30. Lukas, J., Sorensen, C. S., Lukas, C., Santoni-Rugiu, E., and Bartek, J. (1999). p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis. Oncogene 18, 3930-3935.
31. Meraldi, P., Honda, R., and Nigg, E. A. (2004). Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. 14, 29-36.
32. Motwani, M., Delohery, T. M., and Schwartz, G. K. (1999). Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells. Clin. Cancer Res. 5, 1876-1883.
33. Motwani, M., Li, X., and Schwartz, G. K. (2000). Flavopiridol, a cyclin-dependent kinase inhibitor, prevents spindle inhibitor-induced endoredupli-cation in human cancer cells. Clin. Cancer Res. 6, 924-932.
34. 2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-gamma. Proc. Natl. Acad. Sci. USA 99, 5971-5976.
35. Niculescu, A. B., 3rd, Chen, X., Smeets, M., Hengst, L., Prives, C., and Reed, S. I. (1998). Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629-643.
36. Nigg, E. A. (2001). Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. 2, 21-32.
37. Rubin, S. M., Gall, A. L., Zheng, N., and Pavletich, N. P. (2005). Structure of the Rb C-terminal domain bound to E2F1-DP1, a mechanism for phosphory-lation-induced E2F release. Cell 123, 1093-1106.
38. Sakakura, C., et al. (2001). Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824-831.
39. Sugiyama, K., Sugiura, K., Hara, T., Sugimoto, K., Shima, H., Honda, K., Furukawa, K., Yamashita, S., and Urano, T. (2002). Aurora-B associated protein phosphatases as negative regulators of kinase activation. Oncogene 21, 3103-3111.
40. Tong, T., et al. (2004). Overexpression of Aurora-A contributes to malignant development of human esophageal squamous cell carcinoma. Clin. Cancer Res. 10, 7304-7310.
41. Tse, A., and Schwartz, G. K. (2004). Potentiation of cytotoxicity of topoisom-erase I poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res. 64, 6635-6644.
42. Weinberg, R. A. (1995). The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
43. Wilkinson, R. W., et al. (2007). AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clin. Cancer Res. 13, 3682-3688.
44. Williams, J. P., Stewart, T., Li, B., Mulloy, R., Dimova, D., and Classon, M. (2006). The retinoblastoma protein is required for Ras-induced oncogenic transformation. Mol. Cell. Biol. 26, 1170-1182.
45. Xu, C. F., Lu, Y., Ma, J., Mohammadi, M., and Neubert, T. A. (2005). Identifixation of phosphopeptides by MALDI Q-TOF MS in positive and negative ion modes after methyl esterification. Mol. Cell Proteom. 4, 809-818.